2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman has been researched along with Coronary Disease in 1 studies
*Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boerwinkle, E; Cai, J; Chen, H; Dai, Y; Daviglus, M; Feofanova, EV; Grove, ML; Jia, P; Kaplan, RC; Laurie, CC; Morrison, AC; North, KE; Qi, Q; Yu, B | 1 |
1 other study(ies) available for 2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman and Coronary Disease
| Article | Year |
|---|---|
A Genome-wide Association Study Discovers 46 Loci of the Human Metabolome in the Hispanic Community Health Study/Study of Latinos.
Topics: Adult; Chromans; Cohort Studies; Coronary Disease; Cytochrome P450 Family 4; Diabetes Mellitus, Type 2; Female; Gene Expression; Genetic Predisposition to Disease; Genome-Wide Association Study; Genome, Human; Hispanic or Latino; Humans; Male; Membrane Transport Proteins; Metabolome; Middle Aged; Phenotype; Polymorphism, Single Nucleotide; Propionates; Public Health; Quantitative Trait Loci; Quantitative Trait, Heritable; Vitamin E | 2020 |